Neoliquiritin

CAS No. 5088-75-5

Neoliquiritin( —— )

Catalog No. M19441 CAS No. 5088-75-5

Neoliquiritin may possess ytotoxiciy and Tumor-specificity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 95 In Stock
5MG 86 In Stock
10MG 122 In Stock
25MG 204 In Stock
50MG 296 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Neoliquiritin
  • Note
    Research use only, not for human use.
  • Brief Description
    Neoliquiritin may possess ytotoxiciy and Tumor-specificity.
  • Description
    Neoliquiritin may possess ytotoxiciy and Tumor-specificity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5088-75-5
  • Formula Weight
    418.4
  • Molecular Formula
    C21H22O9
  • Purity
    >98% (HPLC)
  • Solubility
    Pyridine Methanol etc.:Soluble;Ethanol:Soluble;DMSO:Soluble
  • SMILES
    C1[C@H](OC2=C(C1=O)C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC=C(C=C4)O
  • Chemical Name
    (S)-2-(4-hydroxyphenyl)-7-(((2S3R4S5S6R)-345-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Yinxiancaoside C

    Yinxiancaoside C has antitumor effect.

  • Norsanguinarine

    Norsanguinarine has antifungal activity, it exhibits 100 % inhibition of A. brassicicola and C. maculans at 1000 ppm whereas. It shows significant cytotoxic activities (ED (50) values < 4 microg/ml) against P-388, KB16, A549, and HT-29 cell lines.

  • Xinidamine

    Xinidamine (BRN 0891979) has antitumor activity and can be used to study benign prostatic hyperplasia, macular degeneration and prostatic intraepithelial neoplasia .